Podcast

Podcast: This Week in Managed Care—GOP Releases Part of Its Healthcare Plan and Other Health News

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

Every week, The American Journal of Managed Care® recaps the top managed care news of the week.

This week, the top managed care news included the average Affordable Care Act premiums falling 4%; the FDA approving a triple combination treatment for cystic fibrosis; House Republicans releasing part 1 of their healthcare plan.

iTunes

TuneIn

Stitcher

Spotify

Listen above or through one of these podcast services:

While Waiting for ACA Decision, HHS Says 2020 Benchmark Plan Premiums Mostly Lower

FDA Approves Novel Triple Combination Therapy for Cystic Fibrosis

What We're Reading: Republicans Release Health Plan; J&J's Talc Problems; House Panel to Consider Vape Tax

Blood Supply Falls Short of Need in Most Countries, Study Finds

Black Patients With Diabetes May Have Greater Hospital Readmission Risk, Study Finds

Patient-Centered Oncology Care®—Innovation and Quality: New Directions in Value-Based Care

Read more about the stories in this podcast:

Related Videos
Image credit: Medical technology and futuristic concept. Doctor hologram modern virtual screen interface | SOMKID - stock.adobe.com
JC Scott, CEO and president of The Pharmaceutical Care Management Association (PCMA)
Elizabeth Grush, MBA
Cathy Eng, MD, FACP, FASCO, Vanderbilt-Ingram Cancer Center
Erin Weber, MS
Kenny Cole, MD
Joseph Saseen, PharmD
Adam Colburn, JD, associate vice president for congressional affairs, AMCP
Andrew Evens, DO
Screenshot from interview with Andrew Evens, DO
Related Content
Missy Hopson, PhD
April 16th 2025

Empowering Teams Begins With Human Connection: Missy Hopson, PhD

Kyle Munz Missy Hopson, PhD
Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the power of community reputation for encouraging health care careers, and the influence of empowered workforces on patient outcomes.
Managed Care Cast Thumbnail
April 15th 2025

Personalized Care Key as Tirzepatide Use Expands Rapidly

Maggie L. Shaw John W. Ostrominski, MD
Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Rural health sign | Image credit: BJP7images - stock.adobe.com
April 15th 2025

FQHCs Show Low Engagement in Hypertension, Diabetes Trials

Pearl Steinzor
A new review finds federally qualified health centers (FQHCs) are underutilized in hypertension and type 2 diabetes clinical research, despite their potential to improve trial diversity.
Managed Care Cast Presents: Unlocking the Potential of CGM Technology
April 10th 2025

Managed Care Cast Presents: Unlocking the Potential of CGM Technology

Laura Joszt, MA
A group of experts discusses the use of continuous glucose monitoring (CGM) technology in diabetes and its transformative potential in managing the disease.
Patient taking survey | Image Credit: terovesalainen - stock.adobe.com
April 15th 2025

EHR-Based Symptom Inventory Shows Potential for Ovarian Cancer Monitoring

Brooke McCormick
The electronic health record (EHR)–based symptom inventory identified symptom prevalence and associated comorbidities, but no ovarian cancers were diagnosed during the study period.
Pharmacy online_evso - adobe.stock.com
April 15th 2025

SGLT2 Inhibitors Show Renal Benefits in HF and CKD as Prescribers Target Uptake Gaps

Giuliana Grossi
Abstracts featured at the National Kidney Foundation Spring Clinical Meeting highlighted the renoprotective benefits of SGLT2 inhibitors in heart failure and diabetic kidney disease while emphasizing the need for strategies to increase their uptake in primary care.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo